Fairmount Partners Assists MatTek in Sale to CELLINK

March 22, 2021 – As announced on March 10, 2021, CELLINK AB (publ) (“CELLINK”) a Swedish company traded on Nasdaq Stockholm entered into an agreement to acquire the American company MatTek Corporation (“MatTek”), focusing on advanced in-vitro technology for clinical and pre-clinical studies offering in-vitro human tissue model innovation, cell isolation and cell culture. CELLINK […]